MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-07-0013730
Blured Pharmaceuticals Private Limited - pharma in Arcot, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.87 Cr
▼ 2% YoY
Net profit · FY 2024
₹17.96 Lakh
Net margin 6.3%
EBITDA · FY 2024
₹24.69 Lakh
EBITDA margin 8.6%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹3.28 Cr
Issued & subscribed
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Blured Pharmaceuticals Private Limited
Data last updated:
Blured Pharmaceuticals Private Limited is a private limited company based in Arcot, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24100TN2015PTC101840. Its GSTIN is 33AAGCB4050L1ZT (Tamil Nadu).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹3.28 Cr. It is led by directors Jayakumar Sadhanandam and Subramaniyan Balanagarajan.
Its last annual general meeting (AGM) was held on 29 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Arcot, Tamil Nadu.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.87 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹17.96 Lakh (net margin 6.3%) and EBITDA of ₹24.69 Lakh (EBITDA margin 8.6%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 2% over five years.
Court records list 1 case involving the company, including 1 filed against it.
Blured Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-07-0013730). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bluredpharma.com.
Company details
CIN U24100TN2015PTC101840
Registration Number 101840
Incorporation Date 17 August 2015
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-07-0013730
Recognitions & Rankings of Blured Pharmaceuticals
Contact details
Blured Pharmaceuticals Private Limited's registered office is in Arcot, Tamil Nadu. Its website is bluredpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressDoor No 140 Bazaar Street, Vazhaipandal Ranipet District, Arcot, Tamil Nadu, India – 632318
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Blured Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Blured Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Blured Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Blured Pharmaceuticals Private Limited, buy the company report.
Financials of Blured Pharmaceuticals Private Limited
FY 2024 filings availableBlured Pharmaceuticals Private Limited reported revenue of ₹2.87 Cr (down 2% YoY) for FY 2024.
Revenue · FY 2024
₹2.87 Cr ▼ 2%
Net profit · FY 2024
₹17.96 Lakh margin 6.3%
EBITDA · FY 2024
₹24.69 Lakh margin 8.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 2%
3 years · compounded
▼ 5%
5 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▼ 34%
3 years · compounded
▼ 25%
5 years · compounded
▲ 11%
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹24.69 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.96 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.6% | ||||
| Net Profit Margin | 6.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Blured Pharmaceuticals Private Limited, buy the company report.
Board of directors of Blured Pharmaceuticals Private Limited
Blured Pharmaceuticals has 2 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayakumar Sadhanandam | Director | 31 May 2019 | 7 Years 4 Months | Current |
| Subramaniyan Balanagarajan | Director | 28 Nov 2021 | 4 Years 10 Months | Current |
Auditor
Blured Pharmaceuticals Private Limited is audited by S. Shanmugam for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S. Shanmugam | FY 2023 | 208141 |
Shareholding
The shareholding of Blured Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Blured Pharmaceuticals Private Limited, buy the company report.
Legal cases
Blured Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Erode, Tamil Nadu | Criminal case | Filed against the company by an individual | Disposed |
To see the full case history of Blured Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Blured Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Blured Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAGCB4050L1ZT | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Blured Pharmaceuticals Private Limited, buy the company report.
Recent activity
Blured Pharmaceuticals Private Limited has 19 board changes on record since 2019: 2 appointments and 17 cessations. The latest: Ayyakannu Sivakumar ceased to be Director on 20 Mar 2024.
AGM
Blured Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2024 as per latest MCA records.
Filing
Blured Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Ceased
Ayyakannu Sivakumar ceased to be Director.
Ceased
Narasimman Suresh ceased to be Director.
Ceased
Chandrasekaran Abimuktheeswaran ceased to be Additional Director.
Ceased
Subramaniyan Balanagarajan ceased to be Additional Director.
Ceased
Gnanavelu Kasthuri ceased to be Director.
Appointed
Subramaniyan Balanagarajan was appointed as Director.
Ceased
Jayakumar Sadhanandam ceased to be Additional Director.
Ceased
Krishnamoorthi Dharmalingam ceased to be Director.
Ceased
Arumugam Sekar ceased to be Additional Director.
Ceased
Arunachalam Muthukkumari ceased to be Additional Director.
10 earlier events are in the company report.
Frequently asked questions
Blured Pharmaceuticals is an active private limited company based in Arcot, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 August 2015 (11+ years old) and is registered under CIN U24100TN2015PTC101840.
Blured Pharmaceuticals has 2 current directors:
- Jayakumar Sadhanandam - Director
- Subramaniyan Balanagarajan - Director
The latest financial statements of Blured Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 29 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Blured Pharmaceuticals is 33AAGCB4050L1ZT, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Blured Pharmaceuticals is U24100TN2015PTC101840. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Blured Pharmaceuticals has 1 court case on record: 1 filed against it.
Blured Pharmaceuticals was incorporated on 17 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Chennai.
Ayyakannu Sivakumar ceased to be Director on 20 Mar 2024. Narasimman Suresh ceased to be Director on 20 Mar 2024. Chandrasekaran Abimuktheeswaran ceased to be Additional Director on 30 Sep 2022. Blured Pharmaceuticals has 19 board changes on record in total.
Yes, Blured Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-07-0013730).
Blured Pharmaceuticals can be reached through the website bluredpharma.com. Its registered office is in Arcot, Tamil Nadu, India.